GL1X · GenesisL1 explorer

Ligand · 435

435 · 4-[(E)-(4-hydroxy-3,5-dimethylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide

435, 4-[(E)-(4-hydroxy-3,5-dimethylphenyl)diazenyl]-N-(pyridin-2-yl)benzenesulfonamide (C19 H18 N4 O3 S, 382.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…

Component
435
Formula
C19 H18 N4 O3 S
Class
ligand
Structures
2
PDB entries
1

Binding sites

435 in 2 structures; the first of them:

  • 4NUC · Crystal structure of the first bromodomain of human BRD4 in complex with MS435 inhibitor · 435 A201 · binds TRP81, PRO82, PHE83, GLN85, VAL87, LYS91, LEU92, LEU94 and 4 more
  • 4NUC · Crystal structure of the first bromodomain of human BRD4 in complex with MS435 inhibitor · 435 A201 · binds TRP81, PRO82, PHE83, GLN85, VAL87, LYS91, LEU92, LEU94 and 4 more

Residues it binds most

LEU 2, TYR 2, ASN 2, GLN 2, ILE 2, LYS 2, PHE 2, PRO 2, TRP 2, VAL 2 (residue and the binding sites it lines).

Found with

  • EDO · 1,2-ethanediol

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.